Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-6-16
pubmed:commentsCorrections
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1827-6806
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
229-32
pubmed:meshHeading
pubmed-meshheading:20550063-Adrenergic beta-Antagonists, pubmed-meshheading:20550063-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:20550063-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:20550063-Clinical Trials as Topic, pubmed-meshheading:20550063-Heart Failure, pubmed-meshheading:20550063-Heart Rate, pubmed-meshheading:20550063-Homeostasis, pubmed-meshheading:20550063-Humans, pubmed-meshheading:20550063-Myocardial Contraction, pubmed-meshheading:20550063-Nerve Growth Factor, pubmed-meshheading:20550063-Norepinephrine, pubmed-meshheading:20550063-Receptors, Adrenergic, beta, pubmed-meshheading:20550063-Sympathetic Nervous System, pubmed-meshheading:20550063-Time Factors, pubmed-meshheading:20550063-Up-Regulation, pubmed-meshheading:20550063-Ventricular Dysfunction, pubmed-meshheading:20550063-Ventricular Remodeling
pubmed:year
2010
pubmed:articleTitle
[Adrenergic activation in heart failure: blockade or rebalance?].
pubmed:publicationType
Editorial, Comment